{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-043488","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2026-09-21T13:12:01+00:00","discovered_at":"2026-09-21T13:13:02.307471+00:00","generated_at":"2026-09-21T13:13:12.160407+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InspireMD amends warrants, potential $11M proceeds tied to anticipated FDA approval of CGuard Prime 80 cm","bullets":["Amended Series J (4.8M shares) and Series K (9.5M shares) warrants; exercise price for amended portion set at $0.7674.","Potential gross proceeds up to $11M if exercised; no additional warrants issued.","Termination date changed to May 15, 2028 or 20 trading days after FDA approval announcement; approval expected Q4 2026.","Unchanged Series J half retains $1.3827 exercise price and SwitchGuard trigger.","CGuard Prime 80 cm shows 100% acute success, zero MAEs at 30 days in 36-patient study; TCAR market doubles addressable opportunity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-043488","json":"https://secwatch.observer/filing/0001493152-26-043488.json","markdown":"https://secwatch.observer/filing/0001493152-26-043488.md","text":"https://secwatch.observer/filing/0001493152-26-043488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/0001493152-26-043488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-21T13:13:12.160407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}